Rating History for Ascendis Pharma (ASND) by Wolfe Research
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 3/2/2026 | Kalpit Patel | Maintain | Outperform (N/A) |
260.00 (255.00) |
|
Details | |
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 3/2/2026 | Kalpit Patel | Maintain | Outperform (N/A) |
260.00 (255.00) |
|
Details | |
![]() |
|||||||